Loading news...
A Media Snippet accompanying this announcement is available by clicking on this link.
InMode (NASDAQ: INMD - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their analyst recommendations, risk, institutional ownership, profitability, earnings, dividends and valuation. Valuation and Earnings This table compares InMode and Jushi"s
This week could be a big trading week for marijuana stocks to kick off 2026. At this time, there is a lot of speculation on what is next to come. These thoughts have been had for a long time, while most legal operators have been working in a grey area. Now that cannabis is considered a less harmful substance in the eyes of the government, more progress can be made. Not just that, for most marijuana stock investors, there is a safer roadmap towards profitability.
Resonate Blends (OTCMKTS:KOAN - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their valuation, profitability, earnings, risk, analyst recommendations, institutional ownership and dividends. Risk and Volatility Resonate Blends has a beta
InterCure (NASDAQ: INCR - Get Free Report) and Jushi (OTCMKTS:JUSHF - Get Free Report) are both medical companies, but which is the superior stock? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, risk, valuation, dividends and profitability. Insider and Institutional Ownership 8.3% of InterCure shares are held
In 2026, marijuana stocks could see a rise in trading throughout different parts of the year. Often, when a strong catalyst moves in the industry, it also moves marijuana stocks. Now, where that market movement is up or down depends on what causes it. So, for example, when quarterly earnings look good or reform measures are being pushed, it helps cannabis stocks. The more positive speculation that circulates, the better the odds of seeing a rise in trading.
Jushi Holdings Inc. (OTCQX:JUSHF) Q3 2025 Earnings Call November 4, 2025 4:00 PM EST Company Participants Trenton Woloveck - Co-Chief Strategy Director James Cacioppo - Founder, Chairman & CEO Michelle Mosier - CFO & Chief Accounting Officer Conference Call Participants Luke Hannan - Canaccord Genuity Corp., Research Division Pablo Zuanic - Zuanic & Associates Frederico Yokota Gomes - ATB Capital Markets Inc., Research Division Andrew Semple - Ventum Financial Corp., Research Division Presentation Operator " Trenton Woloveck Co-Chief Strategy Director " James Cacioppo Founder, Chairman & CEO " Michelle Mosier CFO & Chief Accounting Officer " Luke Hannan Canaccord Genuity Corp., Research Division " Canaccord Genuity Corp., Research Division Pablo Zuanic Zuanic & Associates " Cantor Fitzgerald Frederico Yokota Gomes ATB Capital Markets Inc., Research Division " ATB Capital Markets Inc., Research Division Andrew Semple Ventum Financial Corp., Research Division " Ventum Financial Corp., Research Division Operator Good afternoon. My name is Bailey, and I will be your conference operator today.
Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.12 per share versus the Zacks Consensus Estimate of a loss of $0.05. This compares to a loss of $0.08 per share a year ago.
BOCA RATON, Fla., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH) (OTCQX: JUSHF), a vertically integrated, multi-state cannabis operator, announced that it expects to report its financial results for the third quarter ended September 30, 2025, on Tuesday, November 4, 2025.
In today's marijuana stock market, investors are hyper-focused on any reason to sell. Why becuase most shareholders have been holding their positions for some time. Much of the sector has been trading at all-time lows, leading more to find the best marijuana stocks to buy. Yet, many shareholders believe that it will take more than a company being profitable as a business to move the market. That is why most shareholders have been adjusting their strategies and outlook on how to invest in pot stocks.
At times, what happens in the cannabis industry does not always reflect the market. Meaning just becuase companies are doing well does not mean marijuana stocks will follow the same path. Yet in recent trading, there are some marijuana stocks that have begun to show both. Over the last few months, companies have been reporting their Q2 2025 earnings, and with talks on pushing federal reform forward, trading has increased.
Marijuana stocks are slowly moving back down in the stock market. Some who read this may think they have been down so long, what's the difference? Over the last few years, there have been only a few developments that have truly impacted trading for the better. Those things are circulated throughout the company profitably, in line with the overall business and reform on all levels. Even in other global regions, politics and laws play a big part in the future growth and progress of the industry in its entirety.
A Media Snippet accompanying this announcement is available by clicking on this link.
Looking at legal cannabis from a global perspective, it is amazing how far things have come. What was once a big deal to many has almost been eliminated as a public concern or taboo. Places like Canada are the first to fully legalize cannabis, as it should be in the US and Europe. Both hold tremendous value to the overall progress of the legal cannabis worldwide.
Marijuana stock investors are waiting patiently with high hopes. Over the last two weeks, the cannabis sector has seen some strong upward trading. This came after Donald Trump expressed his stance on federal reform, stating that he believes there is a place for it. Once that message hit the public, a bulk of the top marijuana stocks began to run. The profits that were taken were a nice pay for some and a restored confidence in what can happen.
Now that the focus for marijuana stocks is long-term investing, what are those who want profits now to do? Well, the short answer is that people can only control the market to a certain extent, yet in this case, it's day by day, even with a fall in overall value for the cannabis industry in the USA, along with the fall in trading for most pot stocks.
Jushi Holdings Inc. (OTCQX:JUSHF) Q2 2025 Earnings Conference Call August 5, 2025 4:00 PM ET Company Participants James Anthony Cacioppo - Founder, Chairman & CEO Louis Jonathan Barack - Founder, President, Chief Revenue Officer & Corporate Secretary Michelle O. Mosier - CFO & Chief Accounting Officer Trenton Woloveck - Co-Chief Strategy Director Conference Call Participants Andrew Semple - Ventum Financial Corp., Research Division Frederico Yokota Choucair Gomes - ATB Capital Markets Inc., Research Division Luke Hannan - Canaccord Genuity Corp., Research Division Pablo Ernesto Zuanic - Zuanic & Associates Operator Good afternoon.
Jushi Holdings Inc. (JUSHF) came out with a quarterly loss of $0.06 per share in line with the Zacks Consensus Estimate. This compares to a loss of $0.01 per share a year ago.
Revenue of $65.0 million , Reflecting Year-over-Year and Sequential Growth Net Loss of $12.3 million, Compared to $17.0 million in the First Quarter of 2025 Adjusted EBITDA Increased 39.6% Quarter-over-Quarter to $13.7 million, Up From $9.8 million in Q1 2025 Retail Expansion Plan On Track with 40 Stores Nationwide and Counting; Four Additional Store Openings Planned for the Second Half of 2025 BOCA RATON, Fla, Aug. 05, 2025 (GLOBE NEWSWIRE) -- Jushi Holdings Inc. (“Jushi” or the “Company”) (CSE: JUSH ) ( OTCQX: JUSHF ), a vertically integrated, multi-state cannabis operator, is pleased to announce its financial results for the second quarter ended June 30, 2025 (“Q2 2025”). All financial information is unaudited and provided in U.S. dollars unless otherwise indicated and is prepared under U.S. Generally Accepted Accounting Principles (“GAAP”).
Are you buying marijuana stocks or holding onto old positions, and what is keeping investors going? It's the speculation that may take place even though the entire cannabis industry has fallen by the billions. Still, some see the opportunity in the transition and evolution of the legal cannabis industry. The uncertainty of federal reform and other global and US industry issues gives shareholders more concern. Yet the market is not dead, and consumer demand is rising, so the light at the end of the tunnel will be the companies that are most profitable and compliant.